{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:38:53Z","timestamp":1792604333305,"version":"4.5.0"},"publisher-location":"Cham","reference-count":133,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032294364","type":"print"},{"value":"9783032294371","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-29437-1_34","type":"book-chapter","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:55:26Z","timestamp":1792601726000},"page":"555-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Multiple Reaction Monitoring (MRM) for Targeted Proteomics in Biomedical Research"],"prefix":"10.1007","author":[{"given":"Elyssa N.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timon","family":"Geib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph H.","family":"Borchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2027,1,23]]},"reference":[{"key":"34_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/gm364","volume":"4","author":"ES Baker","year":"2012","unstructured":"Baker ES et al. (2012) Mass spectrometry for translational proteomics: progress and clinical implications. Genome Med 4: 63","journal-title":"Genome Med"},{"key":"34_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/nprot.2017.040","volume":"12","author":"OT Schubert","year":"2017","unstructured":"Schubert OT, R\u00f6st HL, Collins BC, Rosenberger G, Aebersold R (2017) Quantitative proteomics: challenges and opportunities in basic and applied research. Nat Protoc 12:1289\u20131294","journal-title":"Nat Protoc"},{"key":"34_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.aca.2017.01.059","volume":"964","author":"V Vidova","year":"2017","unstructured":"Vidova V, Spacil Z (2017) A review on mass spectrometry-based quantitative proteomics: targeted and data independent acquisition. Anal Chim Acta 964:7\u201323","journal-title":"Anal Chim Acta"},{"key":"34_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4155\/bio.09.185","volume":"2","author":"E Ciccimaro","year":"2010","unstructured":"Ciccimaro E, Blair IA (2010) Stable-isotope dilution LC\u2013MS for quantitative biomarker analysis. Bioanalysis 2:311\u2013341","journal-title":"Bioanalysis"},{"key":"34_CR5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1021\/acs.analchem.5b03004","volume":"88","author":"SL Arnold","year":"2016","unstructured":"Arnold SL, Stevison F, Isoherranen N (2016) Impact of sample matrix on accuracy of peptide quantification: assessment of calibrator and internal standard selection and method validation. Anal Chem 88:746\u2013753","journal-title":"Anal Chem"},{"key":"34_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/bfgp\/eln056","volume":"8","author":"AK Yocum","year":"2009","unstructured":"Yocum AK, Chinnaiyan AM (2009) Current affairs in quantitative targeted proteomics: multiple reaction monitoring\u2013mass spectrometry. Brief Funct Genomic Proteomic 8:145\u2013157","journal-title":"Brief Funct Genomic Proteomic"},{"key":"34_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinms.2020.06.001","volume":"17","author":"C Schuster","year":"2020","unstructured":"Schuster C, Habler K, Vogeser M (2020) Averaging of results derived from different, simultaneously acquired mass transitions in ID-LC-MS\/MS \u2013 potential impact on measurement imprecision. Clin Mass Spectrom 17:1\u20133","journal-title":"Clin Mass Spectrom"},{"key":"34_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fonc.2017.00013","volume":"7","author":"SS Faria","year":"2017","unstructured":"Faria SS et al. (2017) A timely shift from shotgun to targeted proteomics and how it can be groundbreaking for cancer research. Front Oncol 7:13","journal-title":"Front Oncol"},{"key":"34_CR9","doi-asserted-by":"publisher","first-page":"1900029","DOI":"10.1002\/pmic.201900029","volume":"20","author":"CA Sobsey","year":"2020","unstructured":"Sobsey CA et al. (2020) Targeted and untargeted proteomics approaches in biomarker development.  Proteomics 20:1900029","journal-title":"Proteomics"},{"key":"34_CR10","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1021\/ja00475a072","volume":"100","author":"RA Yost","year":"1978","unstructured":"Yost RA, Enke CG (1978) Selected ion fragmentation with a tandem quadrupole mass spectrometer. J Am Chem Soc 100:2274\u20132275","journal-title":"J Am Chem Soc"},{"key":"34_CR11","doi-asserted-by":"publisher","first-page":"100416","DOI":"10.1016\/j.mcpro.2022.100416","volume":"21","author":"C Steiner","year":"2022","unstructured":"Steiner C, Lescuyer P, Cutler P, Tille J-C, Ducret A (2022) Relative quantification of proteins in formalin-fixed paraffin-embedded breast cancer tissue using multiplexed mass spectrometry assays. Mol Cell Proteomics 21:100416","journal-title":"Mol Cell Proteomics"},{"key":"34_CR12","doi-asserted-by":"publisher","first-page":"e952","DOI":"10.1038\/tp.2016.194","volume":"6","author":"RW Paterson","year":"2016","unstructured":"Paterson RW et al. (2016) A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer\u2019s disease pathology. Transl Psychiatry 6:e952\u2013e952","journal-title":"Transl Psychiatry"},{"key":"34_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61496-z","volume":"10","author":"M Makridakis","year":"2020","unstructured":"Makridakis M et al. (2020) Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma. Sci Rep 10: 4815","journal-title":"Sci Rep"},{"key":"34_CR14","doi-asserted-by":"publisher","unstructured":"Yao X, McShane AJ, Castillo M J (2013) Quantitative proteomics in development of disease protein biomarkers. In: Proteomic and metabolomic approaches to biomarker discovery. Academic Press, pp 259\u2013278. https:\/\/doi.org\/10.1016\/B978-0-12-394446-7.00017-0","DOI":"10.1016\/B978-0-12-394446-7.00017-0"},{"key":"34_CR15","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1021\/acs.jproteome.6b00115","volume":"16","author":"C Chiva","year":"2017","unstructured":"Chiva C, Sabid\u00f3 E (2017) Peptide selection for targeted protein quantitation. J. Proteome Res 16:1376\u20131380","journal-title":"J. Proteome Res"},{"key":"34_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1373\/clinchem.2015.250563","volume":"62","author":"AN Hoofnagle","year":"2016","unstructured":"Hoofnagle AN et al. (2016) Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry\u2013based assays. Clin Chem 62:48\u201369","journal-title":"Clin Chem"},{"key":"34_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/pmic.201100387","volume":"12","author":"ES Boja","year":"2012","unstructured":"Boja ES, Rodriguez H (2012) Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics 12:1093\u20131110","journal-title":"Proteomics"},{"key":"34_CR18","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.3390\/molecules29235808","volume":"29","author":"A Tsakalof","year":"2024","unstructured":"Tsakalof A et al. (2024) Current role and potential of triple quadrupole mass spectrometry in biomedical research and clinical applications. Molecules 29:5808.","journal-title":"Molecules"},{"key":"34_CR19","unstructured":"Schreiber A, Pace N (2010) Intelligent use of retention time during multiple reaction monitoring for faster and extended compound screening with\u00a0higher sensitivity and better reproducibility. https:\/\/sciex.com\/content\/dam\/SCIEX\/pdf\/tech-notes\/all\/mass-spectrometry-Multiple-Reaction-1282310.pdf"},{"key":"34_CR20","unstructured":"Bhattacharyya D (2018) LC-MS innovations: review of the technology and its advancements. https:\/\/documents.thermofisher.com\/TFS-Assets\/CMD\/Reference-Materials\/wp-65145-lc-ms-innovations-wp65145-en.pdf"},{"key":"34_CR21","unstructured":"Agilent (2021) Agilent 6495CLC\/TQ best practices guide. https:\/\/www.agilent.com\/cs\/library\/brochures\/best-practices-guide-6495c-5994-4317-en-agilent.pdf"},{"key":"34_CR22","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1002\/pmic.201500449","volume":"16","author":"T Shi","year":"2016","unstructured":"Shi T et al. (2016) Advances in targeted proteomics and applications to biomedical research. Proteomics 16:2160\u20132182","journal-title":"Proteomics"},{"key":"34_CR23","unstructured":"Evosep (2023) The standard methods booklet. https:\/\/www.evosep.com\/wp-content\/uploads\/2023\/06\/The-standard-methods-booklet-2023.pdf"},{"key":"34_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ymeth.2013.05.004","volume":"61","author":"CM Colangelo","year":"2013","unstructured":"Colangelo CM, Chung L, Bruce C, Cheung K-H (2013) Review of software tools for design and analysis of large scale MRM proteomic datasets. Methods 61:287\u2013298","journal-title":"Methods"},{"key":"34_CR25","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1021\/bi400110b","volume":"52","author":"DC Liebler","year":"2013","unstructured":"Liebler DC, Zimmerman LJ (2013) Targeted quantitation of proteins by mass spectrometry. Biochemistry 52:3797\u20133806","journal-title":"Biochemistry"},{"key":"34_CR26","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1074\/mcp.M700132-MCP200","volume":"6","author":"J Stahl-Zeng","year":"2007","unstructured":"Stahl-Zeng J et al. (2007) High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol Cell Proteomics 6:1809\u20131817","journal-title":"Mol Cell Proteomics"},{"key":"34_CR27","unstructured":"Hunter C, Simons B (2012) The scheduled MRM\u2122 algorithm enables intelligent use of retention time during multiple reaction monitoring. https:\/\/sciex.com\/content\/dam\/SCIEX\/pdf\/tech-notes\/all\/mass-spectrometry-ScheduledMRM-0921010.pdf"},{"key":"34_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep43959","volume":"7","author":"W Lu","year":"2017","unstructured":"Lu W et al. (2017) Locus-specific retention predictor (LsRP): a peptide retention time predictor developed for precision proteomics. Sci Rep 7: 43959","journal-title":"Sci Rep"},{"key":"34_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/pmic.201100463","volume":"12","author":"C Escher","year":"2012","unstructured":"Escher C et al. (2012) Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12:1111\u20131121","journal-title":"Proteomics"},{"key":"34_CR30","unstructured":"Agilent (2023) Agilent 6495 triple quadrupole LC\/MS system - intelligence that inspires confidence. https:\/\/www.agilent.com\/cs\/library\/brochures\/6495-triple-quadrupole-lc-ms-5994-6082en-agilent.pdf"},{"key":"34_CR31","unstructured":"Wu L, Fan A, Wang D, Yeh P (2025) Large-panel targeted proteomics with single-cell-equivalent sensitivity using Nanoflow 6495D LC\/TQ. https:\/\/www.agilent.com\/cs\/library\/applications\/an-targeted-proteomics-sensitivity-nanoflow-lc-tq-6495d-5994-8670en-agilent.pdf"},{"key":"34_CR32","unstructured":"Moore I, Deng M, Kern R (2020) Sensitivity gains for the evolution of routine bioanalysis. https:\/\/sciex.com\/content\/dam\/SCIEX\/pdf\/tech-notes\/all\/higher-sensitivity-small-molecule-bioanalysis.pdf"},{"key":"34_CR33","unstructured":"Kern R, Hunter C (2020) Ultrasensitive bioanalytical quantification with minimal method development time. https:\/\/sciex.com\/content\/dam\/SCIEX\/tech-notes\/pharma\/bioanalysis-pk\/ruo-mkt-02-12617\/bioanalytical-quant-of-mmae.pdf"},{"key":"34_CR34","unstructured":"Waters (2022) Xevo TQ-XS instrument capabilities. https:\/\/www.waters.com\/content\/dam\/waters\/en\/library\/specifications\/2022\/waters-specification-XevoTQXSInstrumentCapabilities-720006803.pdf"},{"key":"34_CR35","doi-asserted-by":"publisher","first-page":"100212","DOI":"10.1016\/j.mcpro.2022.100212","volume":"21","author":"C Gaither","year":"2022","unstructured":"Gaither C, Popp R, Zahedi RP, Borchers CH (2022) Multiple reaction monitoring-mass spectrometry enables robust quantitation of plasma proteins regardless of whole blood processing delays that may occur in the clinic. Mol Cell Proteomics  21:100212","journal-title":"Mol Cell Proteomics"},{"key":"34_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s42003-023-05687-0","volume":"7","author":"SA Michaud","year":"2024","unstructured":"Michaud SA et al. (2024) Multiple reaction monitoring assays for large-scale quantitation of proteins from 20 mouse organs and tissues. Commun Biol 7:6","journal-title":"Commun Biol"},{"key":"34_CR37","unstructured":"Evosep (2025) Application Note: Evosep Eno - high sensitivity and quantitative accuracy for plasma proteome analysis at scale. https:\/\/www.evosep.com\/wp-content\/uploads\/2025\/06\/AN-044F_Targeted-workflows_Eno.pdf"},{"key":"34_CR38","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1074\/mcp.M800540-MCP200","volume":"8","author":"MA Kuzyk","year":"2009","unstructured":"Kuzyk MA et al. (2009) Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 8:1860\u20131877","journal-title":"Mol Cell Proteomics"},{"key":"34_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1161\/CIRCGENETICS.111.959528","volume":"5","author":"GV Cohen Freue","year":"2012","unstructured":"Cohen Freue GV, Borchers CH (2012) Multiple reaction monitoring (MRM). Circ Cardiovasc Genet 5:378\u2013378","journal-title":"Circ Cardiovasc Genet"},{"key":"34_CR40","unstructured":"Agilent (2020) Agilent 6495 triple quadrupole LC\/MS with iFunnel Technology. https:\/\/quantum.ee\/wp-content\/uploads\/pdf\/agilent-6495-lcqqq-specifications.pdf"},{"key":"34_CR41","unstructured":"Waters (2022) Xevo TQ-XS instrument capabilities. https:\/\/www.waters.com\/content\/dam\/waters\/en\/library\/specifications\/2022\/waters-specification-XevoTQXSInstrumentCapabilities-720006803.pdf"},{"key":"34_CR42","unstructured":"SCIE (2020) X. SCIEX Triple QuadTM 7500 LC-MS\/MS System \u2013 QTRAP\u00ae ready product brochure. https:\/\/sciex.com\/content\/dam\/SCIEX\/pdf\/brochures\/7500brochure.pdf"},{"key":"34_CR43","doi-asserted-by":"publisher","first-page":"18415","DOI":"10.1021\/acs.analchem.5c02808","volume":"97","author":"Y Wang","year":"2025","unstructured":"Wang Y et al. (2025) Liquid chromatographic and mass spectrometric methods for quantitative proteomic analysis from single cell and nanogram level samples. Anal Chem 97:18415\u201318422","journal-title":"Anal Chem"},{"key":"34_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13973-x","volume":"11","author":"Y Bian","year":"2020","unstructured":"Bian Y et al. (2020) Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC\u2013MS\/MS. Nat Commun 11: 157","journal-title":"Nat Commun"},{"key":"34_CR45","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1074\/mcp.TIR118.000853","volume":"17","author":"N Bache","year":"2018","unstructured":"Bache N et al. (2018) A novel LC system embeds analytes in pre-formed gradients for rapid, ultra-robust proteomics. Mol Cell Proteomics 17:2284\u20132296","journal-title":"Mol Cell Proteomics"},{"key":"34_CR46","unstructured":"Evosep (2023) The standard methods booklet. https:\/\/www.evosep.com\/wp-content\/uploads\/2023\/06\/The-standard-methods-booklet-2023.pdf"},{"key":"34_CR47","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nbt0710-659","volume":"28","author":"MW Duncan","year":"2010","unstructured":"Duncan MW, Aebersold R, Caprioli RM (2010) The pros and cons of peptide-centric proteomics. Nat Biotechnol 28:659\u2013664","journal-title":"Nat Biotechnol"},{"key":"34_CR48","doi-asserted-by":"publisher","first-page":"100212","DOI":"10.1016\/j.mcpro.2022.100212","volume":"21","author":"C Gaither","year":"2022","unstructured":"Gaither C, Popp R, Zahedi RP, Borchers CH (2022) Multiple reaction monitoring-mass spectrometry enables robust quantitation of plasma proteins regardless of whole blood processing delays that may occur in the clinic. Mol Cell Proteomics  21:100212","journal-title":"Mol Cell Proteomics"},{"key":"34_CR49","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1021\/acs.jproteome.1c00249","volume":"20","author":"C Gaither","year":"2021","unstructured":"Gaither C et al. (2021) Performance assessment of a 125 human plasma peptide mixture stored at room temperature for multiple reaction monitoring\u2013mass spectrometry. J Proteome Res 20:4292\u20134302","journal-title":"J Proteome Res"},{"key":"34_CR50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1039\/D4AN00967C","volume":"150","author":"C Gaither","year":"2025","unstructured":"Gaither C, Popp R, Gajadhar AS, Borchers CH (2025) Reproducible protein quantitation of 270 human proteins at increased depth using nanoparticle-based fractionation and multiple reaction monitoring mass spectrometry with stable isotope-labelled internal standards. Analyst 150:353\u2013361","journal-title":"Analyst"},{"key":"34_CR51","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1021\/pr500753r","volume":"13","author":"ES Boja","year":"2014","unstructured":"Boja ES, Fehniger TE, Baker MS, Marko-Varga G, Rodriguez H (2014) Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers. J Proteome Res 13:5325\u20135332","journal-title":"J Proteome Res"},{"key":"34_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-4939-3524-6_13","volume":"1410","author":"JR Whiteaker","year":"2016","unstructured":"Whiteaker JR et al. (2016) Using the CPTAC assay portal to identify and implement highly characterized targeted proteomics assays. Methods Mol Biol 1410:223\u2013236","journal-title":"Methods Mol Biol"},{"key":"34_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/prca.201700045","volume":"11","author":"L Yang","year":"2017","unstructured":"Yang L et al. (2017) An alpha-synuclein MRM assay with diagnostic potential for Parkinson\u2019s disease and monitoring disease progression. Proteomics Clin Appl 11:7\u20138. https:\/\/doi.org\/10.1002\/prca.201700045","journal-title":"Proteomics Clin Appl"},{"key":"34_CR54","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/prca.201400178","volume":"9","author":"DS Spellman","year":"2015","unstructured":"Spellman DS et al. (2015) Development and evaluation of a multiplexed mass spectrometry-based assay for measuring candidate peptide biomarkers in alzheimer\u2019s disease neuroimaging initiative (ADNI) CSF. Proteomics Clin Appl 9:715\u2013731","journal-title":"Proteomics Clin Appl"},{"key":"34_CR55","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1021\/acs.jproteome.1c00532","volume":"20","author":"TT van Duijl","year":"2021","unstructured":"van Duijl TT et al. (2021) Development and provisional validation of a multiplex LC-MRM-MS test for timely kidney injury detection in urine. J Proteome Res 20:5304\u20135314","journal-title":"J Proteome Res"},{"key":"34_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1074\/mcp.M116.064758","volume":"16","author":"Y-T Chen","year":"2017","unstructured":"Chen Y-T et al. (2017) Development of a multiplexed liquid chromatography multiple-reaction-monitoring mass spectrometry (LC-MRM\/MS) method for evaluation of salivary proteins as oral cancer biomarkers. Mol Cell Proteomics 16:799\u2013811","journal-title":"Mol Cell Proteomics"},{"key":"34_CR57","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1074\/mcp.O115.049957","volume":"14","author":"AG Chambers","year":"2015","unstructured":"Chambers AG, Percy AJ, Yang J, Borchers CH (2015) Multiple reaction monitoring enables precise quantification of 97 proteins in dried blood spots. Mol Cell Proteomics 14:3094\u20133104","journal-title":"Mol Cell Proteomics"},{"key":"34_CR58","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1074\/mcp.M800540-MCP200","volume":"8","author":"MA Kuzyk","year":"2009","unstructured":"Kuzyk MA et al. (2009) Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 8:1860\u20131877","journal-title":"Mol Cell Proteomics"},{"key":"34_CR59","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1021\/pr500317d","volume":"13","author":"AJ Percy","year":"2014","unstructured":"Percy AJ et al. (2014) Multiplexed MRM with internal standards for cerebrospinal fluid candidate protein biomarker quantitation. J Proteome Res 13:3733\u20133747","journal-title":"J Proteome Res"},{"key":"34_CR60","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1016\/j.jprot.2011.12.031","volume":"75","author":"Y-T Chen","year":"2012","unstructured":"Chen Y-T et al. (2012) Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers. J Proteomics 75:3529\u20133545","journal-title":"J Proteomics"},{"key":"34_CR61","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1074\/mcp.M500331-MCP200","volume":"5","author":"L Anderson","year":"2006","unstructured":"Anderson L, Hunter CL (2006) Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5:573\u2013588","journal-title":"Mol Cell Proteomics"},{"key":"34_CR62","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3390\/molecules28083323","volume":"28","author":"AS Kononikhin","year":"2023","unstructured":"Kononikhin AS et al. (2023) Targeted MRM quantification of urinary proteins in chronic kidney disease caused by glomerulopathies. Molecules 28:3323.","journal-title":"Molecules"},{"key":"34_CR63","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/14789450.2025.2504994","volume":"22","author":"K Arnarson","year":"2025","unstructured":"Arnarson K et al. (2025) Optimization of bottom-up proteomic sample preparation by design of experiments for absolute quantification of 257 proteins in human plasma using UPLC-MRM-MS. Expert Rev Proteomics 22:209\u2013216","journal-title":"Expert Rev Proteomics"},{"key":"34_CR64","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/acs.jproteome.4c00576","volume":"24","author":"CA Sobsey","year":"2025","unstructured":"Sobsey CA, Batist G, Borchers CH (2025) Characterization of 53 multiplexed targeted proteomics assays for verification studies in cancer cell lines. J Proteome Res 24:459\u2013471","journal-title":"J Proteome Res"},{"key":"34_CR65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ymeth.2013.05.004","volume":"61","author":"CM Colangelo","year":"2013","unstructured":"Colangelo CM, Chung L, Bruce C, Cheung K-H (2013) Review of software tools for design and analysis of large scale MRM proteomic datasets. Methods 61:287\u2013298","journal-title":"Methods"},{"key":"34_CR66","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jprot.2014.04.018","volume":"106","author":"Y Mohammed","year":"2014","unstructured":"Mohammed Y et al. (2014) PeptidePicker: a scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments. J Proteomics 106:151\u2013161","journal-title":"J Proteomics"},{"key":"34_CR67","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/14789450.2025.2557023","volume":"22","author":"Y Mohammed","year":"2025","unstructured":"Mohammed Y, Bhowmick P, Borchers CH (2025) MRMAssayDB: a comprehensive integrated resource for targeted proteomics assays. Expert Rev Proteomics 22:421\u2013432","journal-title":"Expert Rev Proteomics"},{"key":"34_CR68","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1093\/bioinformatics\/bty385","volume":"34","author":"P Bhowmick","year":"2018","unstructured":"Bhowmick P, Mohammed Y, Borchers CH (2018) MRMAssayDB: an integrated resource for validated targeted proteomics assays. Bioinformatics 34:3566\u20133571","journal-title":"Bioinformatics"},{"key":"34_CR69","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1021\/acs.jproteome.0c00961","volume":"20","author":"P Bhowmick","year":"2021","unstructured":"Bhowmick P, Roome S, Borchers CH, Goodlett DR, Mohammed Y (2021) An update on MRMAssayDB: a comprehensive resource for targeted proteomics assays in the community. J Proteome Res 20:2105\u20132115","journal-title":"J Proteome Res"},{"key":"34_CR70","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1021\/acs.jproteome.4c01079","volume":"24","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol Y et al. (2025) Open-source and FAIR research software for proteomics. J Proteome Res 24:2222\u20132234","journal-title":"J Proteome Res"},{"key":"34_CR71","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B et al. (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966\u2013968","journal-title":"Bioinformatics"},{"key":"34_CR72","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mas.21540","volume":"39","author":"LK Pino","year":"2020","unstructured":"Pino LK et al. (2020) The skyline ecosystem: informatics for quantitative mass spectrometry proteomics. Mass Spectrom Rev 39:229\u2013244","journal-title":"Mass Spectrom Rev"},{"key":"34_CR73","doi-asserted-by":"publisher","first-page":"100212","DOI":"10.1016\/j.mcpro.2022.100212","volume":"21","author":"C Gaither","year":"2022","unstructured":"Gaither C, Popp R, Zahedi RP, Borchers CH (2022) Multiple reaction monitoring-mass spectrometry enables robust quantitation of plasma proteins regardless of whole blood processing delays that may occur in the clinic. Mol Cell Proteomics 21:100212","journal-title":"Mol Cell Proteomics"},{"key":"34_CR74","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3390\/biomedicines12102403","volume":"12","author":"AS Kononikhin","year":"2024","unstructured":"Kononikhin AS et al. (2024) Absolute quantitative targeted monitoring of potential plasma protein biomarkers: a pilot study on healthy individuals. Biomedicines 12:2403.","journal-title":"Biomedicines"},{"key":"34_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nprot.2010.196","volume":"6","author":"AN Kettenbach","year":"2011","unstructured":"Kettenbach AN, Rush J, Gerber SA (2011) Absolute quantification of protein and post-translational modification abundance with stable isotope\u2013labeled synthetic peptides. Nat Protoc 6:175\u2013186","journal-title":"Nat Protoc"},{"key":"34_CR76","doi-asserted-by":"publisher","first-page":"e16061","DOI":"10.15252\/emmm.202216061","volume":"15","author":"J Hartl","year":"2023","unstructured":"Hartl J et al. (2023) Quantitative protein biomarker panels: a path to improved clinical practice through proteomics. EMBO Mol Med 15:e16061","journal-title":"EMBO Mol Med"},{"key":"34_CR77","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jprot.2010.04.004","volume":"73","author":"T-C Chao","year":"2010","unstructured":"Chao T-C, Hansmeier N, Halden RU (2010) Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery. J Proteomics 73:1641\u20131646","journal-title":"J Proteomics"},{"key":"34_CR78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/B978-0-08-099387-4.00003-X","volume":"39","author":"A Otto","year":"2012","unstructured":"Otto A, Bernhardt J, Hecker M, V\u00f6lker U, Becher D (2012) Proteomics: from relative to absolute quantification for systems biology approaches. Methods Microbiol 39:81\u2013106. https:\/\/doi.org\/10.1016\/B978-0-08-099387-4.00003-X","journal-title":"Methods Microbiol"},{"key":"34_CR79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fchem.2014.00058","volume":"2","author":"R Chaube","year":"2014","unstructured":"Chaube R (2014) Absolute quantitation of post-translational modifications. Front Chem 2:58","journal-title":"Front Chem"},{"key":"34_CR80","doi-asserted-by":"publisher","unstructured":"Mohammed Y, Goodlett D, Borchers CH (2023) Absolute quantitative targeted proteomics assays for plasma proteins. In: Greening DW, Simpson RJ (eds) Serum\/plasma proteomics: methods and protocols. Springer US, New York, NY, pp 439\u2013473. https:\/\/doi.org\/10.1007\/978-1-0716-2978-9_27","DOI":"10.1007\/978-1-0716-2978-9_27"},{"key":"34_CR81","doi-asserted-by":"publisher","first-page":"104661","DOI":"10.1016\/j.biosystems.2022.104661","volume":"215\u2013216","author":"E Dubois","year":"2022","unstructured":"Dubois E, Galindo AN, Dayon L, Cominetti O (2022) Assessing normalization methods in mass spectrometry-based proteome profiling of clinical samples. Biosystems 215\u2013216:104661","journal-title":"Biosystems"},{"key":"34_CR82","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acsmeasuresciau.3c00068","volume":"4","author":"Y Jiang","year":"2024","unstructured":"Jiang Y et al. (2024) Comprehensive overview of bottom-up proteomics using mass spectrometry. ACS Meas Sci Au 4:338\u2013417","journal-title":"ACS Meas Sci Au"},{"key":"34_CR83","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1016\/j.csbj.2022.08.022","volume":"20","author":"S-X Phua","year":"2022","unstructured":"Phua S-X, Lim K-P, Goh WW-B (2022) Perspectives for better batch effect correction in mass-spectrometry-based proteomics. Comput Struct Biotechnol J 20:4369\u20134375","journal-title":"Comput Struct Biotechnol J"},{"key":"34_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64718-y","volume":"16","author":"Q Chen","year":"2025","unstructured":"Chen Q et al. (2025) Protein-level batch-effect correction enhances robustness in MS-based proteomics. Nat Commun 16: 9735","journal-title":"Nat Commun"},{"key":"34_CR85","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-1-4939-9744-2_16","volume":"2051","author":"J \u010cuklina","year":"2020","unstructured":"\u010cuklina J, Pedrioli PGA, Aebersold R (2020) Review of batch effects prevention, diagnostics, and correction approaches.. Methods Mol 2051:373\u2013387","journal-title":"Methods Mol"},{"key":"34_CR86","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.mcpro.2025.100974","volume":"24","author":"Y Mohammed","year":"2025","unstructured":"Mohammed Y et al. (2025) SysQuan: repurposing SILAC mice for the cost-effective absolute quantitation of the human proteome. Mol Cell Proteomics 24:100974","journal-title":"Mol Cell Proteomics"},{"key":"34_CR87","unstructured":"SysQuan. SysQuan: Absolute proteome quantification for human & mouse tissue. https:\/\/sysquan.com. Accessed 30 Jul 2026."},{"key":"34_CR88","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nbt.1546","volume":"27","author":"TA Addona","year":"2009","unstructured":"Addona TA et al. (2009) Multi-site assessment of the precision and reproducibility of multiple reaction monitoring\u2013based measurements of proteins in plasma. Nat Biotechnol 27:633\u2013641","journal-title":"Nat Biotechnol"},{"key":"34_CR89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s42003-023-05687-0","volume":"7","author":"SA Michaud","year":"2024","unstructured":"Michaud SA et al. (2024) Multiple reaction monitoring assays for large-scale quantitation of proteins from 20 mouse organs and tissues. Commun Biol 7:6","journal-title":"Commun Biol"},{"key":"34_CR90","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/clinchem\/hvaa178","volume":"66","author":"M Do","year":"2020","unstructured":"Do M et al. (2020) Clinical application of multiple reaction monitoring-mass spectrometry to human epidermal growth factor receptor 2 measurements as a potential diagnostic tool for breast cancer therapy. Clin Chem 66:1339\u20131348","journal-title":"Clin Chem"},{"key":"34_CR91","doi-asserted-by":"publisher","first-page":"765898","DOI":"10.3389\/fimmu.2021.765898","volume":"12","author":"JR Whiteaker","year":"2021","unstructured":"Whiteaker JR et al. (2021) Targeted mass spectrometry enables multiplexed quantification of immunomodulatory proteins in clinical biospecimens. Front Immunol 12:765898","journal-title":"Front Immunol"},{"key":"34_CR92","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1021\/acs.jproteome.3c00324","volume":"23","author":"Y Mohammed","year":"2024","unstructured":"Mohammed Y et al. (2024) Proteomic evolution from acute to post-COVID-19 conditions. J\u00a0Proteome Res 23:52\u201370","journal-title":"J Proteome Res"},{"key":"34_CR93","doi-asserted-by":"publisher","first-page":"10816","DOI":"10.1021\/acs.analchem.1c00975","volume":"93","author":"S Ibrahim","year":"2021","unstructured":"Ibrahim S et al. (2021) Precise quantitation of PTEN by immuno-MRM: a tool to resolve the breast cancer biomarker controversy. Anal Chem 93:10816\u201310824","journal-title":"Anal Chem"},{"key":"34_CR94","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.3390\/ijms26189219","volume":"26","author":"DN Korobkov","year":"2025","unstructured":"Korobkov DN et al. (2025) Multiplexed quantitation of plasma proteins by targeted mass spectrometry for early diagnosis of pancreatic ductal adenocarcinoma. Int J Mol Sci 26:9219","journal-title":"Int J Mol Sci"},{"key":"34_CR95","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3803\/EnM.2024.1985","volume":"39","author":"SY Kwon","year":"2024","unstructured":"Kwon SY, Kim K-J, Lee S-Y, Kim JH (2024) Comparative analysis of liquid chromatography-tandem mass spectrometry and radioimmunoassay in determining plasma aldosterone concentration and plasma renin activity for primary aldosteronism screening. Endocrinol Metab 39:965\u2013969","journal-title":"Endocrinol Metab"},{"key":"34_CR96","doi-asserted-by":"publisher","first-page":"E1097","DOI":"10.1210\/jc.2012-3861","volume":"98","author":"C Ohlsson","year":"2013","unstructured":"Ohlsson C et al. (2013) Comparisons of immunoassay and mass spectrometry measurements of serum estradiol levels and their influence on clinical association studies in men. J Clin Endocrinol Metab 98:E1097\u2013E1102","journal-title":"J Clin Endocrinol Metab"},{"key":"34_CR97","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1210\/clinem\/dgaf159","volume":"110","author":"LA Nierves","year":"2025","unstructured":"Nierves LA et al. (2025) Biomarkers, proteoforms, and mass spectrometry\u2013based assays for diabetes clinical research. J Clin Endocrinol Metab 110:1514\u20131523","journal-title":"J Clin Endocrinol Metab"},{"key":"34_CR98","first-page":"A149","volume":"105","author":"C Tonry","year":"2019","unstructured":"Tonry C et al. (2019) BS15 multiplexed measurement of protein biomarkers of cardiovascular disease in blood. Heart 105:A149\u2013A149","journal-title":"Heart"},{"key":"34_CR99","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/ijms22020838","volume":"22","author":"M Brioschi","year":"2021","unstructured":"Brioschi M et al. (2021) Multiplexed MRM-based proteomics identified multiple biomarkers of disease severity in human heart failure. Int J Mol Sci 22:838","journal-title":"Int J Mol Sci"},{"key":"34_CR100","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12933-024-02125-1","volume":"23","author":"F Piarulli","year":"2024","unstructured":"Piarulli F et al. (2024) Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus. Cardiovasc Diabetol 23:36","journal-title":"Cardiovasc Diabetol"},{"key":"34_CR101","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1021\/acs.jproteome.9b00824","volume":"19","author":"P Oeckl","year":"2020","unstructured":"Oeckl P et al. (2020) Targeted mass spectrometry suggests beta-synuclein as synaptic blood marker in Alzheimer\u2019s disease. J Proteome Res 19:1310\u20131318","journal-title":"J Proteome Res"},{"key":"34_CR102","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/jnc.14635","volume":"151","author":"EM Cilento","year":"2019","unstructured":"Cilento EM et al. (2019) Mass spectrometry: a platform for biomarker discovery and validation for Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurochem 151:397\u2013416","journal-title":"J Neurochem"},{"key":"34_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05384-8","volume":"12","author":"Y Kim","year":"2022","unstructured":"Kim Y et al. (2022) Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry. Sci Rep 12: 1282","journal-title":"Sci Rep"},{"key":"34_CR104","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijms27010015","volume":"27","author":"PA Strelnikova","year":"2025","unstructured":"Strelnikova PA et al. (2025) Plasma protein panel for assessing the risk of alzheimer\u2019s disease by MRM-MS analysis: the study of two independent clinical cohorts. Int J Mol Sci 27:15","journal-title":"Int J Mol Sci"},{"key":"34_CR105","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1021\/acs.jproteome.3c00557","volume":"23","author":"DO Qasrawi","year":"2024","unstructured":"Qasrawi DO et al. (2024) A simplified proteomics LC-MRM-MS assay for determination of apoe genotypes in plasma samples. J Proteome Res 23:1144\u20131149","journal-title":"J Proteome Res"},{"key":"34_CR106","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae132","volume":"6","author":"CA Leckey","year":"2024","unstructured":"Leckey CA et al. (2024) CSF neurofilament light chain profiling and quantitation in neurological diseases. Brain Commun 6, fcae132.","journal-title":"Brain Commun"},{"key":"34_CR107","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/prca.201400178","volume":"9","author":"DS Spellman","year":"2015","unstructured":"Spellman DS et al. (2015) Development and evaluation of a multiplexed mass spectrometry-based assay for measuring candidate peptide biomarkers in Alzheimer\u2019s disease neuroimaging initiative (ADNI) CSF. Proteomics Clin Appl 9:715\u2013731","journal-title":"Proteomics Clin Appl"},{"key":"34_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-024-03467-x","volume":"11","author":"JR Whiteaker","year":"2024","unstructured":"Whiteaker JR et al. (2024) Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry. Sci Data 11: 682","journal-title":"Sci Data"},{"key":"34_CR109","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1373\/clinchem.2011.173856","volume":"58","author":"AN Hoofnagle","year":"2012","unstructured":"Hoofnagle AN et al. (2012) Multiple reaction monitoring-mass spectrometric assays can accurately measure many protein concentrations in complex mixtures. Clin Chem 58:777\u2013781","journal-title":"Clin Chem"},{"key":"34_CR110","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1074\/mcp.M113.034660","volume":"13","author":"MW Burgess","year":"2014","unstructured":"Burgess MW, Keshishian H, Mani DR, Gillette MA, Carr SA (2014) Simplified and efficient quantification of low-abundance proteins at very high multiplex via targeted mass spectrometry. Mol Cell Proteomics 13:1137\u20131149","journal-title":"Mol Cell Proteomics"},{"key":"34_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.765898","volume":"12","author":"JR Whiteaker","year":"2021","unstructured":"Whiteaker JR et al. (2021) Targeted mass spectrometry enables multiplexed quantification of immunomodulatory proteins in clinical biospecimens. Front. Immunol 12, 765898.","journal-title":"Front. Immunol"},{"key":"34_CR112","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/cancers17233765","volume":"17","author":"C-S Ang","year":"2025","unstructured":"Ang C-S et al. (2025) Evaluation of nanoparticle-based plasma enrichment on individuals with primary and metastatic pancreatic cancer. Cancers 17:3765","journal-title":"Cancers"},{"key":"34_CR113","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1039\/D5AY00721F","volume":"17","author":"Q Wang","year":"2025","unstructured":"Wang Q et al. (2025) High-throughput plasma\/serum proteomics by coupling nanoparticle protein corona-based sample preparation and capillary zone electrophoresis-tandem mass spectrometry. Anal Methods 17:6356\u20136365","journal-title":"Anal Methods"},{"key":"34_CR114","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1021\/acs.jproteome.4c00302","volume":"23","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Meyer JG (2024) Rapid plasma proteome profiling via nanoparticle protein corona and direct infusion mass spectrometry. J Proteome Res 23:3649\u20133658","journal-title":"J Proteome Res"},{"key":"34_CR115","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/14789450.2018.1484283","volume":"15","author":"E Gianazza","year":"2018","unstructured":"Gianazza E, Banfi C (2018) Post-translational quantitation by SRM\/MRM: applications in cardiology. Expert Rev Proteomics 15:477\u2013502","journal-title":"Expert Rev Proteomics"},{"key":"34_CR116","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2144\/000112201","volume":"40","author":"MR Larsen","year":"2006","unstructured":"Larsen MR, Trelle MB, Thingholm TE, Jensen ON (2006) Analysis of posttranslational modifications of proteins by tandem mass spectrometry: mass spectrometry for proteomics analysis. Biotechniques 40:790\u2013798","journal-title":"Biotechniques"},{"key":"34_CR117","doi-asserted-by":"publisher","first-page":"101003","DOI":"10.1016\/j.mcpro.2025.101003","volume":"24","author":"F Wu","year":"2025","unstructured":"Wu F, Li W, Lu H, Li L (2025) Recent advances in mass spectrometry-based studies of post-translational modifications in Alzheimer\u2019s disease. Mol Cell Proteomics 24:101003","journal-title":"Mol Cell Proteomics"},{"key":"34_CR118","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10337-014-2783-9","volume":"78","author":"LR Ruhaak","year":"2015","unstructured":"Ruhaak LR, Lebrilla CB (2015) Applications of multiple reaction monitoring to clinical glycomics. Chromatographia 78:335\u2013342","journal-title":"Chromatographia"},{"key":"34_CR119","doi-asserted-by":"publisher","first-page":"463352","DOI":"10.1016\/j.chroma.2022.463352","volume":"1678","author":"J Brandi","year":"2022","unstructured":"Brandi J, Noberini R, Bonaldi T, Cecconi D (2022) Advances in enrichment methods for mass spectrometry-based proteomics analysis of post-translational modifications. J Chromatogr A 1678:463352","journal-title":"J Chromatogr A"},{"key":"34_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1168710","volume":"13","author":"JR Whiteaker","year":"2023","unstructured":"Whiteaker JR et al. (2023) A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials. Front Oncol 13, 1168710.","journal-title":"Front Oncol"},{"key":"34_CR121","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.crmeth.2021.100015","volume":"1","author":"JR Whiteaker","year":"2021","unstructured":"Whiteaker JR et al. (2021) Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling. Cell Rep Methods 1:100015","journal-title":"Cell Rep Methods"},{"key":"34_CR122","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mas.21741","volume":"42","author":"T-T Lin","year":"2023","unstructured":"Lin T-T et al. (2023) Mass spectrometry-based targeted proteomics for analysis of protein mutations. Mass Spectrom Rev 42:796\u2013821","journal-title":"Mass Spectrom Rev"},{"key":"34_CR123","doi-asserted-by":"publisher","first-page":"101003","DOI":"10.1016\/j.mcpro.2025.101003","volume":"24","author":"F Wu","year":"2025","unstructured":"Wu F, Li W, Lu H, Li L (2025) Recent advances in mass spectrometry-based studies of post-translational modifications in Alzheimer\u2019s disease. Mol Cell Proteomics 24:101003","journal-title":"Mol Cell Proteomics"},{"key":"34_CR124","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.crmeth.2021.100015","volume":"1","author":"JR Whiteaker","year":"2021","unstructured":"Whiteaker JR et al. (2021) Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling. Cell Rep Methods 1:100015","journal-title":"Cell Rep Methods"},{"key":"34_CR125","doi-asserted-by":"publisher","first-page":"M111.014340","DOI":"10.1074\/mcp.M111.014340","volume":"11","author":"LJ Zimmerman","year":"2012","unstructured":"Zimmerman LJ, Li M, Yarbrough WG, Slebos RJC, Liebler DC (2012) Global stability of plasma proteomes for mass spectrometry-based analyses. Mol Cell Proteomics 11:M111.014340","journal-title":"Mol Cell Proteomics"},{"key":"34_CR126","doi-asserted-by":"publisher","first-page":"219452","DOI":"10.1155\/2013\/219452","volume":"2013","author":"JE Hale","year":"2013","unstructured":"Hale JE (2013) Advantageous uses of mass spectrometry for the quantification of proteins. Int J Proteomics 2013:219452","journal-title":"Int J Proteomics"},{"key":"34_CR127","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1021\/pr400877e","volume":"12","author":"D Lin","year":"2013","unstructured":"Lin D, Alborn WE, Slebos RJC, Liebler DC (2013) Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma. J Proteome Res 12:5996\u20136003","journal-title":"J Proteome Res"},{"key":"34_CR128","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1089\/omi.2023.0278","volume":"28","author":"MA Anwar","year":"2024","unstructured":"Anwar MA et al. (2024) Blood-based multiomics-guided detection of a precancerous pancreatic tumor. Omics J Integr Biol 28:182\u2013192","journal-title":"Omics J Integr Biol"},{"key":"34_CR129","doi-asserted-by":"crossref","unstructured":"Isabelle M, Schirm M, Pottiez G, Guilbaud R, Donato LD (2020) 54 patient stratification using clinical proteomics \u2013 validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues. J Immunother Cancer 8","DOI":"10.1136\/jitc-2020-SITC2020.0054"},{"key":"34_CR130","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1158\/1078-0432.CCR-20-3513","volume":"27","author":"M Son","year":"2021","unstructured":"Son M et al. (2021) A clinically applicable 24-protein model for classifying risk subgroups in pancreatic ductal adenocarcinomas using multiple reaction monitoring-mass spectrometry. Clin Cancer Res 27:3370\u20133382","journal-title":"Clin Cancer Res"},{"key":"34_CR131","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1021\/acs.jproteome.4c00644","volume":"24","author":"O Kardell","year":"2025","unstructured":"Kardell O et al. (2025) Multicenter longitudinal quality assessment of MS-based proteomics in plasma and serum. J Proteome Res 24:1017\u20131029","journal-title":"J Proteome Res"},{"key":"34_CR132","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1039\/C8AN01017J","volume":"143","author":"KE Yannell","year":"2018","unstructured":"Yannell KE, Ferreira CR, Tichy S, Cooks RG (2018) Multiple reaction monitoring (MRM)-profiling with biomarker identification by lC-QTOF to characterize coronary artery disease. Analyst 143:5014\u20135022","journal-title":"Analyst"},{"key":"34_CR133","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.crmeth.2021.100015","volume":"1","author":"JR Whiteaker","year":"2021","unstructured":"Whiteaker JR et al. (2021) Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling. Cell Rep Methods 1:100015","journal-title":"Cell Rep Methods"}],"container-title":["Advances in Experimental Medicine and Biology","Advancements of Mass Spectrometry in Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-29437-1_34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:55:29Z","timestamp":1792601729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-3-032-29437-1_34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032294364","9783032294371"],"references-count":133,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-29437-1_34","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"23 January 2027","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}